🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ashley Haggerty

Riverview Medical Center

ORCID: 0000-0002-7064-3189

Also affiliated with Sunshine Coast University Hospital, Hackensack Meridian Health

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer”.

A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.07.008

N/A

0.208DataRank · unranked

3 citations

Ashley Haggerty, Stefan M. Gysler, Sarah E. Taylor, Kian Behbakht, Jill Alldredge +10 more

Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis

American Journal of Obstetrics and Gynecology(2020)10.1016/j.ajog.2020.08.007

N/A

0DataRank · unranked

45 citations

Dimitrios Nasioudis, Stuart Craig, Haley Moss, Nawar Latif, Emily Ko +2 more

Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.08.024

N/A

0DataRank · unranked

117 citations

Stephanie L. Wethington, Cheyenne Pagan, Nawar Latif, János L. Tanyi, Lainie P. Martin +17 more